Literature DB >> 20734710

Three years of HIV/AIDS care and treatment services in Tanzania: achievements and challenges.

G Somi1, M Matee, C L Makene, J Van Den Hombergh, B Kilama, K I Yahya-Malima, P Masako, D Sando, J Ndayongeje, B Rabiel, R O Swai.   

Abstract

The Tanzania HIV Care and Treatment Plan was launched in October 2004 aiming at providing 440,000 AIDS patients with antiretroviral drugs (ARVs) and track disease progression in 1.2 million HIV+ persons by the end of the 2008. This paper is intended to provide information to stake holders of the achievements and challenges of the HIV Care and Treatment Plan since its inception in 2004. Facility patient reports are aggregated at district and then regional level before being sent to the national level where they are aggregated to form a national report. By December 2007, 210 health facilities were offering HIV care and treatment services in Tanzania. About 123,147 (5%) of the 2,636,785 estimated people living with HIV and AIDS were enrolled, and 71,439 (13.6%) of the estimated 527,357 AIDS cases commenced ART. More females than males started ART, F:M ratio being 3:2. Most (49%) patients were started ART due to low CD4 counts (< 200). About 6,618 patients had their initial ARV regimen changed due to starting anti-TB treatment 679 (10%), peripheral neuropathy 812 (12%), skin rash 378 (6%), and stock out 247 (4%) or other reasons (18%), while 2,653 (42%) had no reason recorded. The proportion of patients still alive and on ART at 6, 12 and 24 months after initiation of treatment was 60%, 60%, and 50%, respectively, while those collecting ARVs on schedule was 34%, 25% and 10% respectively. About 3,084 patients developed TB after starting ART, of whom 1,557 (approximately 50%) patients during the first three months of treatment. During the three years (2004-2007) of HIV care and treatment services in Tanzania, there has been an increase in the number of CTC facilities, geographical coverage of services, the number of enrolled patients and those on ART. However, the set target for ART services has not been achieved and there are significant geographical variations in these achievements, which do not correspond with either population density or disease burden. Efforts should be made to i) ensure equitable accessibility when scaling up ART services in Tanzania, ii) improve the recording and reporting system and iii) armonize the activities of various stakeholders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20734710     DOI: 10.4314/thrb.v11i3.47700

Source DB:  PubMed          Journal:  Tanzan J Health Res        ISSN: 1821-9241


  15 in total

1.  Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043).

Authors:  Jessica M Fogel; William Clarke; Michal Kulich; Estelle Piwowar-Manning; Autumn Breaud; Matthew T Olson; Mark A Marzinke; Oliver Laeyendecker; Agnès Fiamma; Deborah Donnell; Jessie K K Mbwambo; Linda Richter; Glenda Gray; Michael Sweat; Thomas J Coates; Susan H Eshleman; Alfred H Chingono
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

2.  Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Authors:  Ralf Weigel; Janne Estill; Matthias Egger; Anthony D Harries; Simon Makombe; Hannock Tweya; Andreas Jahn; Olivia Keiser
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

3.  The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania.

Authors:  Leonard E G Mboera; Deus S Ishengoma; Andrew M Kilale; Isolide S Massawe; Acleus S M Rutta; Gibson B Kagaruki; Erasmus Kamugisha; Vito Baraka; Celine I Mandara; Godlisten S Materu; Stephen M Magesa
Journal:  BMC Health Serv Res       Date:  2015-06-26       Impact factor: 2.655

4.  Coming home to die? The association between migration and mortality in rural Tanzania before and after ART scale-up.

Authors:  Francis Levira; Jim Todd; Honorati Masanja
Journal:  Glob Health Action       Date:  2014-05-21       Impact factor: 2.640

5.  Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions.

Authors:  Gibson B Kagaruki; Mary T Mayige; Ester S Ngadaya; Godfather D Kimaro; Akili K Kalinga; Andrew M Kilale; Amos M Kahwa; Godlisten S Materu; Sayoki G Mfinanga
Journal:  BMC Public Health       Date:  2014-09-02       Impact factor: 3.295

6.  Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: a cross-sectional study.

Authors:  Amani Thomas Mori; Joyce Owenya
Journal:  J Pharm Policy Pract       Date:  2014-04-22

7.  High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.

Authors:  Batya Elul; Paulin Basinga; Harriet Nuwagaba-Biribonwoha; Suzue Saito; Deborah Horowitz; Denis Nash; Jules Mugabo; Veronicah Mugisha; Etienne Rugigana; Richard Nkunda; Anita Asiimwe
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

8.  Reviewing progress: 7 year trends in characteristics of adults and children enrolled at HIV care and treatment clinics in the United Republic of Tanzania.

Authors:  Harriet Nuwagaba-Biribonwoha; Bonita Kilama; Gretchen Antelman; Ahmed Khatib; Annette Almeida; William Reidy; Gongo Ramadhani; Matthew R Lamb; Redempta Mbatia; Elaine J Abrams
Journal:  BMC Public Health       Date:  2013-10-27       Impact factor: 3.295

9.  Improved services to enrollees into an HIV rural care and treatment center in Tanzania.

Authors:  Khadija Said; Abdallah Mkopi; Suzanne Verver; Fred Lwilla; Gavin Churchyard; Seif Shekalaghe; Manuel Battegay; Klaus Reither
Journal:  Pan Afr Med J       Date:  2013-09-30

10.  Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes.

Authors:  Harriet Nuwagaba-Biribonwoha; Aleksandra Jakubowski; Veronicah Mugisha; Paulin Basinga; Anita Asiimwe; Denis Nash; Batya Elul
Journal:  BMC Public Health       Date:  2014-08-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.